Importantly, high levels of LincIN in breast tumors are correlated with advanced pathologic stages and a worse survival outcome, suggesting that LincIN is a promising prognostic biomarker for breast cancer and likely plays a functional role in breast tumor progression/metastasis. This evidence concerns the gene ITGB1-DT and breast carcinoma.